» Articles » PMID: 16827895

E Prostanoid 2 (EP2)/EP4-mediated Suppression of Antigen-specific Human T-cell Responses by Prostaglandin E2

Overview
Journal Immunology
Date 2006 Jul 11
PMID 16827895
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Prostaglandin E2 (PGE2) is a lipid mediator that displays important immunomodulatory properties, such as polarization of cytokine production by T cells. Recent investigations have revealed that the effect of PGE2 on cytokine production is greatly influenced by external stimuli; however, it is unclear whether PGE2 plays a significant role in major histocompatibility complex-mediated antigen-specific T-cell responses via binding to one of four subtypes of E prostanoid (EP) receptor alone or in combination. In the present study, we sought to determine the effect of PGE2 on antigen-specific CD4+ T-cell responses in humans, especially in terms of receptor specificity. We used purified protein derivative (PPD) and Cry j 1 as T helper type 1 (Th1) and Th2-inducing antigens, respectively. We generated several different Cry j 1- and PPD-specific T-cell lines (TCLs). PGE2 significantly and dose-dependently inhibited the proliferation and subsequent production of interleukin-4 by Cry j 1-specific TCLs and of interferon-gamma by PPD-specific TCLs upon antigen stimulation. Administration of EP2 receptor agonist and EP4 receptor agonist suppressed these responses in an adenylate cyclase-dependent manner, while EP1 and EP3 receptor agonists did not. Messenger RNA for EP2, EP3 and EP4, but not EP1, receptors were detected in Cry j 1- and PPD-specific TCLs, and no differences in EP receptor expression were observed between them. Furthermore, PGE2 and EP2 receptor agonist significantly inhibited interleukin-5 and interferon-gamma production by peripheral blood mononuclear cells in response to Cry j 1 and PPD stimulation, respectively. These results suggest that PGE2 suppresses both Th1- and Th2-polarized antigen-specific human T-cell responses via a cAMP-dependent EP2/EP4-mediated pathway.

Citing Articles

Phase II trial of pembrolizumab, ipilimumab, and aspirin in melanoma: clinical outcomes and translational predictors of response.

Quandt Z, Jacob S, Fadlullah M, Wu C, Wu C, Huppert L BJC Rep. 2024; 2(1):46.

PMID: 39516257 PMC: 11524064. DOI: 10.1038/s44276-024-00057-7.


GPCRs: emerging targets for novel T cell immune checkpoint therapy.

Dickinson K, Yee E, Vigil I, Schulick R, Zhu Y Cancer Immunol Immunother. 2024; 73(12):253.

PMID: 39358616 PMC: 11447192. DOI: 10.1007/s00262-024-03801-7.


Recruitment of inflammatory monocytes by senescent fibroblasts inhibits antigen-specific tissue immunity during human aging.

Chambers E, Vukmanovic-Stejic M, Shih B, Trahair H, Subramanian P, Devine O Nat Aging. 2023; 1(1):101-113.

PMID: 37118005 DOI: 10.1038/s43587-020-00010-6.


Airway and Systemic Prostaglandin E2 Association with COPD Symptoms and Macrophage Phenotype.

Tejwani V, Villabona-Rueda A, Khare P, Zhang C, Le A, Putcha N Chronic Obstr Pulm Dis. 2023; 10(2):159-169.

PMID: 36976551 PMC: 10392871. DOI: 10.15326/jcopdf.2022.0375.


Harnessing prostaglandin E signaling to ameliorate autoimmunity.

Burkett J, Doran A, Gannon M Trends Immunol. 2023; 44(3):162-171.

PMID: 36707339 PMC: 9975049. DOI: 10.1016/j.it.2023.01.004.


References
1.
Borger P, Postma D, Vellenga E, Kauffman H . Regulation of asthma-related T-cell cytokines by the cyclic AMP-dependent signalling pathway. Clin Exp Allergy. 2000; 30(7):920-6. DOI: 10.1046/j.1365-2222.2000.00794.x. View

2.
He X, Stuart J . Prostaglandin E2 selectively inhibits human CD4+ T cells secreting low amounts of both IL-2 and IL-4. J Immunol. 1999; 163(11):6173-9. View

3.
Yamatomo T, Okano M, Ono T, Nakayama E, Yoshino T, Satoskar A . Sex-related differences in the initiation of allergic rhinitis in mice. Allergy. 2001; 56(6):525-31. DOI: 10.1034/j.1398-9995.2001.056006525.x. View

4.
Okano M, Kino K, Takishita T, Hattori H, Ogawa T, Yoshino T . Roles of carbohydrates on Cry j 1, the major allergen of Japanese cedar pollen, in specific T-cell responses. J Allergy Clin Immunol. 2001; 108(1):101-8. DOI: 10.1067/mai.2001.115757. View

5.
Nataraj C, Thomas D, Tilley S, Nguyen M, Mannon R, Koller B . Receptors for prostaglandin E(2) that regulate cellular immune responses in the mouse. J Clin Invest. 2001; 108(8):1229-35. PMC: 209534. DOI: 10.1172/JCI13640. View